Triple-Negative Breast CA Risk Up for Blacks With Benign Breast Dz

Share this content:
Triple-Negative Breast CA Risk Up for Blacks With Benign Breast Dz
Triple-Negative Breast CA Risk Up for Blacks With Benign Breast Dz

THURSDAY, Dec. 29, 2016 (HealthDay News) -- African-American (AA) identity is associated with increased risk of triple-negative breast cancer (TNBC) among women with a prior diagnosis of benign breast disease (BBD), according to a study published online Dec. 22 in JAMA Oncology.

In a retrospective analysis of data from a cohort of 2,588 AA and 3,566 white American (WA) women with a biopsy-proven BBD diagnosis, Lisa A. Newman, M.D., M.P.H., from the Henry Ford Health System in Detroit, and colleagues examined whether AA identity is associated with TNBC among women with a prior diagnosis of BBD.

The researchers found that 4.1 percent of AA patients (mean follow-up interval, 6.8 years) and 4.0 percent of WA patients (mean follow-up interval, 6.1 years) developed subsequent breast cancers. In each subset, more than three-quarters of subsequent breast cancers were DCIS or stage I. The 10-year probability estimate for developing TNBC was 0.56 percent (95 percent confidence interval, 0.32 to 1.0 percent) and 0.25 percent (95 percent confidence interval, 0.12 to 0.53 percent) for AA and WA patients, respectively. Among AA patients who developed subsequent invasive breast cancers, 16 of 66 developed TNBC, compared with seven of 94 of the WA patients who developed subsequent invasive breast cancers and had complete biomarker data (24.2 versus 7.4 percent; P = 0.01).

"This study is the largest analysis to date of TNBC in the context of racial/ethnic identity and BBD as risk factors," the authors write. "This finding suggests that AA identity is associated with inherent susceptibility for TNBC pathogenetic pathways."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Osimertinib Tops Standard EGFR-TKI for EGFR NSCLC

Osimertinib Tops Standard EGFR-TKI for <i>EGFR</i>&#43; NSCLC

Significantly longer median progression-free survival for osimertinib in previously untreated NSCLC

Distinct Features for Drug Use-Related Endophthalmitis

Distinct Features for Drug Use-Related Endophthalmitis

Injection drug users have fewer comorbidities and more improvement in visual acuity after intervention

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Nonmedical use of prescription drugs linked to dating violence for male, female high school students

is free, fast, and customized just for you!

Already a member?

Sign In Now »